CREBBP and lymphoid neoplasm: In addition, in the current study, we report for the first time recurrent mutations (5-10%) in CMML in the genes CREBBP, KMT2D and UMODL1, which have been previously reported in lymphoid neoplasms or solid tumors [25, 26].